BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25878337)

  • 1. Discrimination of Candida albicans from Candida dubliniensis by Use of the BioFire FilmArray Blood Culture Identification Panel.
    Southern TR; Alelew A; Iwen PC
    J Clin Microbiol; 2015 Jun; 53(6):1999-2000. PubMed ID: 25878337
    [No Abstract]   [Full Text] [Related]  

  • 2. Does identification to species level provide sufficient evidence to confirm catheter-related fungemia caused by Candida albicans?
    Escribano P; Guinea J; Marcos-Zambrano L; Recio S; Peláez T; Rodríguez-Créixems M; Muñoz P; Bouza E
    Med Mycol; 2013 Oct; 51(7):769-73. PubMed ID: 23815435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida krusei fungemia in 7 neonates: clonality tracked to an infusate.
    Rongpharpi SR; Gur R; Duggal S; Kumar A; Nayar R; Xess I; Wadhwa V; Khanijo CM
    Am J Infect Control; 2014 Nov; 42(11):1247-8. PubMed ID: 25444273
    [No Abstract]   [Full Text] [Related]  

  • 4. Candida albicans or Candida dubliniensis?
    Ells R; Kock JL; Pohl CH
    Mycoses; 2011 Jan; 54(1):1-16. PubMed ID: 19682314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis].
    Mesa LM; Arcaya N; Cañas O; Machado Y; Calvo B
    Rev Iberoam Micol; 2004 Sep; 21(3):135-8. PubMed ID: 15709787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
    Momani OM; Qaddoomi A
    East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis.
    Neppelenbroek KH; Campanha NH; Spolidorio DM; Spolidorio LC; Seó RS; Pavarina AC
    Oral Dis; 2006 May; 12(3):242-53. PubMed ID: 16700733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida kefyr as a cause of bloodstream infection and adjunctive role of biomarkers in its diagnosis.
    Khan Z; Ahmad S; Al-Obaid K; Joseph L; Chandy R
    J Mycol Med; 2015 Mar; 25(1):71-5. PubMed ID: 25442911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary comparative study between identification methods: API 32C® and MALDI-TOF®].
    Ruiz de Alegría Puig C; Armiñanzas C; Agüero Balbín J; Martínez Martínez L; Fariñas MC
    Rev Iberoam Micol; 2014; 31(2):153-4. PubMed ID: 24055843
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.
    Campanha NH; Neppelenbroek KH; Spolidorio DM; Spolidorio LC; Pavarina AC
    Oral Dis; 2005 Nov; 11(6):392-8. PubMed ID: 16269032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis.
    Mähnss B; Stehr F; Schäfer W; Neuber K
    Mycoses; 2005 Jan; 48(1):55-61. PubMed ID: 15679668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of (1-3)-β-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia.
    Mokaddas E; Khan ZU; Ahmad S; Nampoory MR; Burhamah M
    Clin Microbiol Infect; 2011 Oct; 17(10):1549-53. PubMed ID: 21883664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular concordance of concurrent Candida albicans candidemia and candiduria.
    Huang PY; Hung MH; Shie SS; Su LH; Chen KY; Ye JJ; Chiang PC; Leu HS; Huang CT
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):382-4. PubMed ID: 23602783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misidentification of Candida dubliniensis isolates with the VITEK MS.
    Korem M; Cohen MJ; Michael-Gayego A; Castiel D; Assous MV; Amit S
    J Mycol Med; 2021 Mar; 31(1):101107. PubMed ID: 33388671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of molecular typing tools for the study of hospital outbreaks of candidemia].
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    Rev Iberoam Micol; 2014; 31(2):97-103. PubMed ID: 23792122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular surveillance of candidemia due to Candida albicans among cancer patients during 2009 to 2013 by microsatellite typing.
    Li D; Li X; Xia R; Zhang W; Zheng S; Zhang Q; Bai C; Zhang P
    Microb Pathog; 2015 Apr; 81():28-32. PubMed ID: 25769820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusters of patients with candidaemia due to genotypes of Candida albicans and Candida parapsilosis: differences in frequency between hospitals.
    Marcos-Zambrano LJ; Escribano P; Sanguinetti M; Gómez G de la Pedrosa E; De Carolis E; Vella A; Cantón R; Bouza E; Guinea J
    Clin Microbiol Infect; 2015 Jul; 21(7):677-83. PubMed ID: 25882359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of peptide nucleic acid probes for specific identification of Candida albicans.
    Kim HJ; Brehm-Stecher BF
    J Clin Microbiol; 2015 Feb; 53(2):511-21. PubMed ID: 25428160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene.
    Romeo O; Criseo G
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):230-3. PubMed ID: 18640803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-related fungemia caused by Candida dubliniensis.
    Lai CC; Tsai HY; Chang TC; Hsueh PR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):306-8. PubMed ID: 23246304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.